Tradestie Institutional Equity Comparison Engine

NMR vs DCM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NMR Overall Edge

NMR Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nomura Holdings, Inc (NMR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NMR trades at 11.4x Forward P/E with 25.1% operating margin (+17.9% YoY revenue) versus DCM at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, NMR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against DCM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner NMR
NMR 11.4x vs DCM N/M Fwd P/E
Growth & Margin Winner NMR
Op Margin 25.1% vs N/A ยท YoY +17.9% vs N/A
Momentum & Technical Winner NMR
1Y +21.8% vs -34.4% ยท 52W Pos 40% vs 0%
Options & Structure Winner NMR
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$8.51
-5.86% 1D
Market Cap $26.4B
1M Return -5.86%
1Y Return +21.75%
Forward P/E 11.4x
Unified AI Score
35.0 / 100 SELL
Tech 13.0 Fund 35.0 Flow 50.0 Mom 50.0
DCM US Equity
DCM
Institutional Equity
$2.82
-6.62% 1D
Market Cap N/A
1M Return -26.75%
1Y Return -34.42%
Forward P/E N/M
Unified AI Score
48.8 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NMR +21.75% DCM -34.42% Spread: +27.73 pp (NMR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NMR TTM Op. Margin: 25.1% DCM TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs DCM. Trailing 12-month operating profitability (NMR 25.1% vs DCM N/A) and valuation multiples (NMR 11.4x vs DCM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NMR (9) vs DCM (1)
Institutional Metric NMR DCM Criterion Row Winner
Market Capitalization Scale $26.4B N/A Larger Scale NMR
Trailing P/E Ratio Valuation 10.4x N/M Lower Multiple NMR
Forward P/E Ratio Valuation 11.4x N/M Lower Multiple NMR
Revenue Growth (YoY) Growth +17.9% N/A Higher Growth NMR
Operating Margin (TTM) Profitability 25.1% N/A Higher Margin NMR
Net Profit Margin Profitability 17.1% N/A Higher Margin NMR
Return on Equity (ROE) Capital Efficiency 11.5% N/A Higher ROE NMR
52-Week Range Position Momentum 40% ($7โ€“$11) 0% ($3โ€“$5) Stronger Trend NMR
Beta / 30D Volatility Risk Regime 1.04ฮฒ ยท 34% Vol N/A Lower Realized Risk NMR
Unified Institutional Score Composite Signal 35.0 / 100 (SELL) 48.8 / 100 (HOLD) Higher Composite DCM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NMR vs DCM Buy Guide
NMR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live NMR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DCM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DCM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NMR nor DCM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.